Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by StockTRMN8TORon Apr 18, 2018 9:12am
46 Views
Post# 27903293

ISOL is the World's Premiere CBD Company

ISOL is the World's Premiere CBD Company

Scythian will continue to help with Isodiol’s international expansion and will help with distribution in Argentina, Jamaica, and Colombia. Scythian has been making a name for itself in Argentina with supply agreements and plans to further that relationship in the CBD market with Isodiol. We expect to hear more about the initiatives in Jamaica and Colombia in the coming weeks.

Isodiol and Liberty Health announced a strategic distribution partnership for the Florida and Massachusetts market. This is a significant development for Isodiol and we are excited by this partnership. The partnership will improve the distribution of Isodiol branded products within two major medical marijuana markets and we expect this to support revenue growth going forward.

A Stock that Investors Need to Watch

This is a major development for Isodiol and we are bullish on the recent developments. Although the financing was completed at a discount to the current share price, the investors are strategic and add significantly more value than just capital. We are bullish on the investment due to the improved relationships with the investors which are major players in markets that Isodiol is focused on capitalizing on. 

In 2018, Isodiol has been under considerable pressure and the shares have fallen approx. 40% during this time. We think this weakness is overdone and see considerable upside to current levels. Isodiol has been nothing short of an execution story and today’s development is something that investors need to watch. 

Bullboard Posts